Real-World Evidence Generation and Evaluation of Therapeutics : Proceedings of a Workshop

個数:

Real-World Evidence Generation and Evaluation of Therapeutics : Proceedings of a Workshop

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 102 p.
  • 言語 ENG
  • 商品コード 9780309455626
  • DDC分類 615

Full Description

The volume and complexity of information about individual patients is greatly increasing with use of electronic records and personal devices. Potential effects on medical product development in the context of this wealth of real-world data could be numerous and varied, ranging from the ability to determine both large-scale and patient-specific effects of treatments to the ability to assess how therapeutics affect patients' lives through measurement of lifestyle changes.



In October 2016, the National Academies of Sciences, Engineering, and Medicine held a workshop to facilitate dialogue among stakeholders about the opportunities and challenges for incorporating real-world evidence into all stages in the process for the generation and evaluation of therapeutics. Participants explored unmet stakeholder needs and opportunities to generate new kinds of evidence that meet those needs. This publication summarizes the presentations and discussions from the workshop.

Table of Contents

Front Matter
1 Introduction
2 Improving Evidence Generation for Decision Making on Approval and Use of New Treatments: Some Stakeholder Priorities
3 Opportunities for Real-World Data
4 Generating and Incorporating Real-World Evidence into Medical Product Development and Evaluation: Building from Successful Case Studies
5 Potential Strategies for a Way Forward
Appendix A: Bibliography
Appendix B: Workshop Agenda
Appendix C: Participant Biographies
Appendix D: Discussion Paper: Real-World Evidence to Guide theApproval and Use of New Treatments

Contents

1 Front Matter; 2 1 Introduction; 3 2 Improving Evidence Generation for Decision Making on Approval and Use of New Treatments: Some Stakeholder Priorities; 4 3 Opportunities for Real-World Data; 5 4 Generating and Incorporating Real-World Evidence into Medical Product Development and Evaluation: Building from Successful Case Studies; 6 5 Potential Strategies for a Way Forward; 7 Appendix A Bibliography; 8 Appendix B Workshop Agenda; 9 Appendix C Participant Biographies; 10 Appendix D Discussion Paper

最近チェックした商品